A Bristol Myers Squibb -Medicijn whose milestone FDA -approval has launched the primary new mechanism for the therapy of schizophrenia in a long time, an important check has did not help the extension of its use, a disappointing end result that a big tooth within the industrial outlook. The part 3 check evaluated the medication, Cobenfy, as a complement to […]